Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,283 | 3,625 | -221,540 | -303,261 | -89,084 |
| Depreciation Amortization | 1,516 | 1,264 | 80 | 2,705 | 2,002 |
| Income taxes - deferred | -335 | 69 | N/A | N/A | N/A |
| Accounts receivable | -5,022 | -10,492 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -152 | 1,148 | 823 | 1,542 | 4,266 |
| Other Working Capital | -2,232 | 3,465 | -30,209 | 44,063 | 515 |
| Other Operating Activity | 6,074 | 9,939 | 37,748 | 150,988 | 8,190 |
| Operating Cash Flow | $5,132 | $9,018 | $-213,098 | $-103,963 | $-74,111 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -616 | -278 | -753 |
| Purchase Of Investment | N/A | N/A | -319,940 | -302,432 | -252,175 |
| Sale Of Investment | N/A | N/A | 363,328 | 278,580 | 122,640 |
| Purchase Sale Intangibles | -1,200 | -2,400 | N/A | N/A | N/A |
| Other Investing Activity | -1,200 | -2,400 | -56,000 | -80,000 | 0 |
| Investing Cash Flow | $-1,200 | $-2,400 | $-13,228 | $-104,130 | $-130,288 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 449 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 33,235 | 278,246 | N/A |
| Debt Repayment | -500 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 13 | N/A | 2,146 | 184,277 | 138,950 |
| Other Financing Activity | 0 | -4,000 | 0 | 0 | 0 |
| Financing Cash Flow | $-487 | $-3,551 | $35,381 | $462,523 | $138,950 |
| Beginning Cash Position | 4,801 | 1,734 | 296,723 | 42,293 | 107,742 |
| End Cash Position | 8,246 | 4,801 | 105,778 | 296,723 | 42,293 |
| Net Cash Flow | $3,445 | $3,067 | $-190,945 | $254,430 | $-65,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,132 | 9,018 | -213,098 | -103,963 | -74,111 |
| Capital Expenditure | N/A | N/A | -616 | -278 | -753 |
| Free Cash Flow | 5,132 | 9,018 | -213,714 | -104,241 | -74,864 |